BALF data obtained during routine clinical care were retrospectively collected for tumor markers (CEA, CYFRA21-1, NSE, ProGRP), cytokines (IL-6, IL-8, TNF-<i>α</i>, IL-10), ctDNA mutation profiles, and immune-cell subpopulations. This evidence concerns the gene ENO2 and neoplasm.